N-glycolylneuraminic acid-containing GM1 is a new molecule for serum antibody in Guillain-Barre syndrome

Annals of Neurology

Volumn 43, Issue 6, 1998, Pages 829-834

  Odaka, Masaaki ^a   Yuki, Nobuhiro ^a   Yoshino, Hiide ^b   Kasama, Takeshi ^c   Handa, Shizuo ^c   Irie, Fumitoshi ^d   Hirabayashi, Yoshio ^d   Suzuki, Akemi ^e   Hirata, Koichi ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b 1 7 1 Kohnodai   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^e TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; NEURAMINIC ACID DERIVATIVE;

ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; CATTLE; CONTROLLED STUDY; CROSS REACTION; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOGENICITY; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; SERUM;

ANIMALS; AUTOANTIBODIES; BINDING, COMPETITIVE; CATTLE; CHOLERA TOXIN; CHROMATOGRAPHY, THIN LAYER; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; G(M1) GANGLIOSIDE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICE; MOTOR NEURONS; NEURAMINIC ACIDS; POLYRADICULONEUROPATHY; SPINAL CORD;

EID: 0031842849     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410430619     Document Type: Article

References (20)

1. Landi G, D'Alessandro R, Dossi BC, et al. Guillain-Barré syndrome after exogenous gangliosides in Italy. BMJ 1993;307: 1463-1464
2. Illa I, Ortiz N, Gallard E, et al. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following patenterai gangliosides. Ann Neurol 1995;38:218-224
3. Ilyas AA, Willison HJ, Quarles RH, et al. Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann Neurol 1988;23: 440-447
4. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990;40:1900-1902
5. Walsh FS, Cronin M, Koblar S, et al. Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome. J Neuroimmunol 1991;34: 43-51
6. Kusunoki S, Chiba A, Kon K, et al. N-Acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome. Ann Neurol 1994;35:570-576
7. Kusunoki S, Iwamori M, Chiba A, et al. GM1b is a new member of antigen for serum antibody in Guiliam-Barré syndrome. Neurology 1996;47:237-242
8. Yuki N, Taki T, Handa S. Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis. J Neuroimmunol 1996;71:155-161
9. Yuki N, Tagawa Y, Irie F, et al. Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1α. J Neuroimmunol 1997;74:30-34
10. Hirabayashi Y, Nakao T, Matsumoto M, et al. Improved method for large-scale purification of brain gangliosides by Q-Sepharose column chromatography: immunochemical detection of C-series polysialogangliosides in adult bovine brains. J Chromatogr 1988;445:377-384
11. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria fot Guillain-Barré syndrome. Ann Neurol 1990; 27(Suppl):S21-S24
12. Yoshino H, Miyatani N, Saito M, et al. Isolated bovine spinal motoneurons have specific ganglioside antigens recognized by sera from patients with motor neuron disease and motor neuropathy. J Neurochem 1992;59:1684-1691
13. Fishman PH, Pacuszka T, Hom B, Moss J. Modification of ganglioside GM1: effect of lipid moiety on choleragen action. J Biol Ghem 1980;255:7657-7664
14. Nakamura K, Suzuki M, Inagaki F, et al. A new ganglioside showing choleragenoid-binding activity in mouse spleen. J Biochem (Tokyo) 1987;101:825-835
15. Kasama T, Handa S. Structural studies of gangliosides by fast atom bombardment ionization, low-energy collision-activated dissociation, and tandem mass spectrometry. Biochemistry 1991; 30:5621-5624
16. Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605
17. Varki A, Kornfeld S. An autosomal dominant gene regulates the extent of 9-O-acetylation of murine erythrocyte sialic acids. J Exp Med 1980;152:532-544
18. Carpo M, Nobile-Orazio E, Chigorno V, Sonnino S. The anti-oligosaccharide antibodies present in sera from patients with motor neuron disease and neuropathy recognize the A'-glycolylneuraminic acid containing gangliotetrahexosyl oligosaccharide. Glycoconjugate J 1995;12:729-731
19. Higashi H, Naiki M, Matuo S, Okouchi K. Antigen of "serum sickness" type of hetetophile antibodies in human sera: identification as gangliosides with N-glycolylneuraminic acid. Biochem Biophys Res Commun 1977;79:388-395
20. Kato S, Higashi H. N-Glycolylneuraminic acid-containing glycoconjugates, a new tumor associated cell surface antigen known as Hanganutziu-Deicher antigen. Gann Monogr Cancer Res 1988;34:41-50